Covance Tissue Sample Stockpile Is Possible Asset For Genomics Research
Covance sees its stockpile of tissue samples from past clinical trials as a potential asset for building a genomics testing business in the future, the clinical research organization indicated during its second quarter earnings conference call July 26.
You may also be interested in...
Quintiles has secured rights to de-identified Rx data from nine pharmacy chains to help replace the healthcare claims data it will stop receiving from WebMD under the companies' settlement.
Quintiles will convert all aspects of its drug development process, including clinical trial recruitment and physician payment, into web transactions by 2002, the firm indicated during a Jan. 24 conference call announcing its Internet partnership with Healtheon/WebMD.
Covance's web-based clinical trial data collection software licensed from Phase Forward is expected to cut the time required to "clean" clinical trial data for analysis to a week or less, the company said.